GP Pharm S.A.U.

GP Pharm is a privately owned pharmaceutical company focused on the development and manufacturing of peptide-based injectable products and specialized in sustained-release systems (i.e. microspheres and liposomes).

Vertically integrated, GP manages drug development from R&D to market. GP Pharm operates internationally, marketing via its own network in Spain (B2C) and in more than 40 countries via its global partners (B2B - out licensing).

Being widely GMP-approved, GP Pharm offers its expertise to provide third-party companies with CDMO services.